Lisbet Wreghitt

Lisbet Wreghitt has extensive experience in the pharmaceutical industry. Lisbet is currently the Senior Vice President of Operations at Vesper Bio ApS, starting in 2023. Prior to that, they served as the Senior Global Programme Director at Ferring Pharmaceuticals from 2021 to 2023. Lisbet also worked at Orphazyme A/S as the Vice President of Global Development Operations from 2020 to 2021, the Senior Director of Global Development Operations from 2020 to 2020, and the Senior Director and Head of Clinical Operations from 2019 to 2020. Before joining Orphazyme A/S, they held various roles at Ferring Pharmaceuticals and LEO Pharma, including Associate Director, Director of Biometrics, R&D Project Manager, and Clinical Project Manager. Lisbet also has experience at Coloplast as a Clinical Trial Manager and LEO Pharma A/S as a Regulatory Officer.

Lisbet Wreghitt received a Master of Science in Pharmacy from the School of Pharmaceutical Sciences at Københavns Universitet from 1997 to 2002. Furthermore, they pursued Project Management at Mannaz from 2013 to 2016.